![Jordan P. Karp](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jordan P. Karp
Nessuna posizione attualmente
Storia della carriera di Jordan P. Karp
Precedenti posizioni note di Jordan P. Karp
Società | Posizione | Inizio | Fine |
---|---|---|---|
PharmAthene, Inc.
![]() PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Consigliere Generale | 01/06/2008 | 30/01/2014 |
Segretario Aziendale | 17/08/2009 | 30/01/2014 | |
Constellation Energy Group, Inc.
![]() Constellation Energy Group, Inc. Electric UtilitiesUtilities Constellation Energy Group, Inc. supplies power, natural gas and energy products and services. The company was founded on September 22, 1995 and is headquartered in Baltimore, MD. | Consigliere Generale | 02/11/2007 | 02/11/2007 |
MCI Communications Corp.
![]() MCI Communications Corp. Specialty TelecommunicationsCommunications Part of Verizon Communications, Inc., MCI Communications Corp. is an American telecommunications company. The company is based in Washington. MCI Communications was acquired by MCI, Inc. on September 15, 1998 for $42,459.16 million. | Consigliere Generale | 02/06/2001 | 02/06/2001 |
Segretario Aziendale | 02/06/2001 | 02/06/2001 | |
Guilford Pharmaceuticals, Inc.
![]() Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Consigliere Generale | 02/06/2001 | 02/06/2001 |
Segretario Aziendale | 02/06/2001 | 02/06/2001 | |
Mentor Technologies
![]() Mentor Technologies Miscellaneous Commercial ServicesCommercial Services Part of InaCom Corp., Mentor Technologies is a company that specializes in information technology training and education. The company is based in Tulsa, OK. Mentor Technologies was acquired by Vanstar Corp. on June 05, 1996. | Consigliere Generale | 02/06/2001 | 02/06/2001 |
Segretario Aziendale | 02/06/2001 | 02/06/2001 | |
Constellation NewEnergy, Inc.
![]() Constellation NewEnergy, Inc. Electric UtilitiesUtilities Constellation NewEnergy, Inc. provides electricity, natural gas and energy related services. The company was founded in 2002 and is headquartered in Baltimore, MD. | Consigliere Generale | - | - |
Formazione di Jordan P. Karp
The Johns Hopkins University | Undergraduate Degree |
Yale University | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Posizioni
General Counsel | 6 |
Corporate Secretary | 4 |
Undergraduate Degree | 1 |
Settori
Health Technology | 3 |
Utilities | 3 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 6 |
---|---|
Guilford Pharmaceuticals, Inc.
![]() Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
Constellation Energy Group, Inc.
![]() Constellation Energy Group, Inc. Electric UtilitiesUtilities Constellation Energy Group, Inc. supplies power, natural gas and energy products and services. The company was founded on September 22, 1995 and is headquartered in Baltimore, MD. | Utilities |
MCI Communications Corp.
![]() MCI Communications Corp. Specialty TelecommunicationsCommunications Part of Verizon Communications, Inc., MCI Communications Corp. is an American telecommunications company. The company is based in Washington. MCI Communications was acquired by MCI, Inc. on September 15, 1998 for $42,459.16 million. | Communications |
Mentor Technologies
![]() Mentor Technologies Miscellaneous Commercial ServicesCommercial Services Part of InaCom Corp., Mentor Technologies is a company that specializes in information technology training and education. The company is based in Tulsa, OK. Mentor Technologies was acquired by Vanstar Corp. on June 05, 1996. | Commercial Services |
Constellation NewEnergy, Inc.
![]() Constellation NewEnergy, Inc. Electric UtilitiesUtilities Constellation NewEnergy, Inc. provides electricity, natural gas and energy related services. The company was founded in 2002 and is headquartered in Baltimore, MD. | Utilities |
PharmAthene, Inc.
![]() PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Health Technology |
- Borsa valori
- Insiders
- Jordan P. Karp
- Esperienza